Advanced in Virilizing Ovarian Tumor
Advanced in Virilizing Ovarian Tumor
Mission Cancer And Blood, PLLC
1221 Pleasant St, Suite 100, 
Des Moines, IA 
 (747.6 mi)

Overview

Joshua Lukenbill is an Oncologist and a Hematologist in Des Moines, Iowa. Dr. Lukenbill and is rated as an Advanced provider by MediFind in the treatment of Virilizing Ovarian Tumor. His top areas of expertise are Lung Cancer, Multiple Myeloma, Small Cell Lung Cancer (SCLC), Bone Marrow Aspiration, and Prostatectomy. Dr. Lukenbill is currently accepting new patients.

His clinical research consists of co-authoring 6 peer reviewed articles and participating in 117 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Oncology
Hematology
Hematology Oncology
Licenses
Internal Medicine in IA
Hospital Affiliations
St Anthony Regional Hospital & Nursing Home
Trinity Regional Medical Center
Unitypoint Health - Des Moines Iowa Methodist Medi
Van Diest Medical Center
Mercyone Des Moines Medical Center
Languages Spoken
English
Gender
Male

Insurance

Please contact the provider to confirm they accept your insurance or if you don't see your insurance listed.

Accepted insurance plans

  •  Wellmark
  •  Medica
  •  Oscar
  •  Humana

Locations

MISSION CANCER AND BLOOD, PLLC
1221 Pleasant St, Suite 100, Des Moines, IA 50309

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


114 Clinical Trials

Integration of Immunotherapy Into Adjuvant Therapy for Resected NSCLC: ALCHEMIST Chemo-IO (ACCIO)
Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial (ALCHEMIST)
RAndomized Phase II/III Trial of Consolidation Radiation + Immunotherapy for ES-SCLC: RAPTOR Trial
Cancer Moonshot Biobank Research Protocol
Optimizing Prolonged Treatment In Myeloma Using MRD Assessment (OPTIMUM)
Molecular Analysis for Therapy Choice (MATCH)
Phase III Randomized Trial of Concurrent Chemoradiotherapy With or Without Atezolizumab in Localized Muscle Invasive Bladder Cancer
Randomized Phase III Trial of MEDI4736 (Durvalumab) as Concurrent and Consolidative Therapy or Consolidative Therapy Alone for Unresectable Stage 3 NSCLC
Randomized Phase II Trial in Early Relapsing or Refractory Follicular Lymphoma
A Randomized Phase III Trial of Endocrine Therapy Plus Entinostat/Placebo in Patients With Hormone Receptor-Positive Advanced Breast Cancer
A Randomized Phase II Trial of Cabozantinib and Cabozantinib Plus Nivolumab Versus Standard Chemotherapy in Patients With Previously Treated Non-Squamous NSCLC
Phase II Study of Bladder-SparIng ChemoradiatioN With Durvalumab in Clinical Stage III, Node PosItive BladdeR CancEr (INSPIRE)
DART: Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors
STAMP: Surgically Treated Adjuvant Merkel Cell Carcinoma With Pembrolizumab, a Phase III Trial
View 35 Less Clinical Trials
Similar Doctors
Distinguished in Virilizing Ovarian Tumor
Oncology | Hematology | Hematology Oncology
Distinguished in Virilizing Ovarian Tumor
Oncology | Hematology | Hematology Oncology

Mission Cancer And Blood, PLLC

1221 Pleasant St, Suite 100, 
Des Moines, IA 
Languages Spoken:
English
Accepting New Patients

Thomas Buroker is an Oncologist and a Hematologist in Des Moines, Iowa. Dr. Buroker and is rated as a Distinguished provider by MediFind in the treatment of Virilizing Ovarian Tumor. His top areas of expertise are Paget Disease of the Breast, Familial Colorectal Cancer, Lung Adenocarcinoma, Bone Marrow Aspiration, and Gastrostomy. Dr. Buroker is currently accepting new patients.

Distinguished in Virilizing Ovarian Tumor
Oncology | Hematology Oncology | Hematology
Distinguished in Virilizing Ovarian Tumor
Oncology | Hematology Oncology | Hematology

Mission Cancer And Blood, PLLC

1221 Pleasant St, Suite 100, 
Des Moines, IA 
Languages Spoken:
English
Accepting New Patients

Daniel Buroker is an Oncologist and a Hematologist Oncology provider in Des Moines, Iowa. Dr. Buroker and is rated as a Distinguished provider by MediFind in the treatment of Virilizing Ovarian Tumor. His top areas of expertise are Pleuropulmonary Blastoma, Lung Cancer, Paget Disease of the Breast, Bone Marrow Aspiration, and Gastrostomy. Dr. Buroker is currently accepting new patients.

Advanced in Virilizing Ovarian Tumor
Hematology Oncology | Oncology | Hematology
Advanced in Virilizing Ovarian Tumor
Hematology Oncology | Oncology | Hematology
1221 Pleasant St, Ste 100, 
Des Moines, IA 
Languages Spoken:
English
Accepting New Patients

Matthew Hill is a Hematologist Oncology specialist and an Oncologist in Des Moines, Iowa. Dr. Hill and is rated as an Advanced provider by MediFind in the treatment of Virilizing Ovarian Tumor. His top areas of expertise are Pleuropulmonary Blastoma, Lung Cancer, Inflammatory Breast Cancer, Bone Marrow Aspiration, and Endoscopy. Dr. Hill is currently accepting new patients.

Areas of Expertise

When evaluating expertise, MediFind pulls from factors such as the number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

To learn more about how MediFind determines the expertise levels, check out our expert tiers page.

Search for your specific condition
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile